The University of California, San Francisco (UCSF), has added RayStation-licenses for expansion at UCSF Medical Center at Mission Bay, California. These licenses add to the existing wide area network infrastructure, as a new facility that will open in 2019, will use RayStation for treatment planning.
This is the third UCSF facility to use RayStation, in addition to the existing centers at UCSF Medical Center at Mount Zion and UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco. Their vision is “Three campuses with one mission”– which will be put into practice by utilizing advanced technologies such as adaptive therapy, advanced automatic planning tools such as Plan Explorer, Fallback Planning and Autobreast planning.
Johan Löf, CEO of RaySearch, says: “UCSF has been a very important partner for us, both for RayStation as well as for RayCare*, our new oncology information system. We are excited to continue our collaboration and give them the best support as they introduce new centers and modalities in the San Francisco area.”
The order was received and mainly generated license revenues in Q3, 2018
UCSF Health is recognized worldwide for its highly innovative patient care, reflecting the latest medical knowledge, advanced technologies and pioneering research. It includes the flagship UCSF Medical Center, which is ranked among the top five hospitals nationwide, as well as UCSF Benioff Children’s Hospitals, with campuses in San Francisco and Oakland, Langley Porter Psychiatric Hospital and Clinics, UCSF Benioff Children’s Physicians and the UCSF Faculty Practice. These hospitals serve as the academic medical center of the University of California, San Francisco, which is world-renowned for its graduate-level health sciences education and biomedical research. UCSF Health has affiliations with hospitals and health organizations throughout the Bay Area.
The information stated above was prepared by RaySearch and reflects solely the opinion of RaySearch. Nothing in this statement shall be construed to imply any support or endorsement of RaySearch, or any of its products, by the Regents of the University of California, its officers, agents and employees.
RayCare represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59